08/31/2017 | Monty Montoya and Shigeru Kinoshita
Monty Montoya and Shigeru Kinoshita on bringing endothelial cell therapy to patients.
08/31/2017 | Sheraz Daya
Can the cornea be "revived" with cadaveric allograft material?
08/31/2017 | Jorge Alió and Jorge Alió del Barrio
The first clinical trial of autologous adipose-derived adult stem cells for the treatment of corneal ectatic disorders.
08/31/2017 | Mark Hillen
How three leading lights and one CEO are tackling corneal disease through pioneering research and development.
08/31/2017 | Bobeck S. Modjtahedi
Lessons in taking a more active role in diabetes care.
08/31/2017 | Ruth Steer
How do patients really feel about their disease – and how do they differ.
Bioactive lipids show promise in protecting against the development of neovascular disease.
Research shows that art training can improve ophthalmologists’ observational skills.
08/30/2017 | Mark Hillen
Protocol I subanalysis suggests that earlier treatment of DME eyes with persistent edema maximizes visual benefit.
08/02/2017 | Ruth Steer
The past, present and future prevalence of AMD in Europe.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: